Jump to Navigation

Facebook Connect

User login

Dyslipidemia: New Challenges and Emerging Options in Lowering CVD Risk - ACTIVITY 1: Challenges in Dyslipidemia Management

New 3-part online continuing education eCourse exploring the changing landscape of dyslipidemia management.  Experts in lipidology examine treatment guidelines, strategies for CV risk reduction, and the value of collaborative care for patients.

Program Description

Aggressive reduction of low-density lipoprotein cholesterol (LDL-C) through lifestyle intervention and statin-based therapy is currently the most effective means of reducing atherosclerotic cardiovascular (CV) disease risk. However, residual risk is substantial in some patients. This may be explained by less than optimal adherence to therapy, adverse events, the potential role of other lipoproteins in CV risk, and insufficient communication among healthcare providers. Activity 1 of this interactive 3-part CME/CPE eCourse series convenes experts in lipidology to compare current guidelines, discuss the potential for further CV risk reduction, and emphasize the importance of a collaborative team in managing patients with dyslipidemia.

Click Here to Launch This Course

Accreditation Information

Content Domain
This activity falls under the following content domain(s):

  • 6.8 Lifestyle Management and CVD Prevention

Learning Objectives
This activity teaches to the following learning objective(s):

  1. Establish a collaborative care practice model to recognize at-risk patients for statin-induced myopathy and myositis and to foster adherence to lipid-lowering medications through monitoring and patient engagement
  2. Incorporate into daily practice current guidelines for the management of cholesterol to reduce CV risk

by Dr. Radut.